Cargando…

A diagnostic autoantibody signature for primary cutaneous melanoma

Melanoma is an aggressive form of skin cancer that is curable by surgical excision in the majority of cases, if detected at an early stage. To improve early stage melanoma detection, the development of a highly sensitive diagnostic test is of utmost importance. Here we aimed to identify antibodies t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaenker, Pauline, Lo, Johnny, Pearce, Robert, Cantwell, Phillip, Cowell, Lester, Lee, Mark, Quirk, Christopher, Law, Henry, Gray, Elin, Ziman, Mel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078131/ https://www.ncbi.nlm.nih.gov/pubmed/30093967 http://dx.doi.org/10.18632/oncotarget.25669

Ejemplares similares

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment
por: Gray, Elin S, et al.
Publicado: (2015)

Checkpoint inhibitor immune-related adverse events: A focused review on autoantibodies and B cells as biomarkers, advancements and future possibilities
por: Taylor, John, et al.
Publicado: (2023)

Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles
por: Aya-Bonilla, Carlos, et al.
Publicado: (2019)

Advances in Personalized Targeted Treatment of Metastatic Melanoma and Non-Invasive Tumor Monitoring
por: Klinac, Dragana, et al.
Publicado: (2013)

Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma
por: Dunkel, Ying, et al.
Publicado: (2018)

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies
por: McEvoy, Ashleigh C., et al.
Publicado: (2019)

Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells
por: Freeman, James B, et al.
Publicado: (2012)

Dual tasking impairments are associated with striatal pathology in Huntington’s disease
por: Lo, Johnny, et al.
Publicado: (2020)

A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision
por: Stark, Mitchell S., et al.
Publicado: (2019)

PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas)
por: Medic, Sandra, et al.
Publicado: (2010)

Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression
por: Warburton, Lydia, et al.
Publicado: (2020)

Multiple melanoma in a burns scar
por: Cantwell, Phillip, et al.
Publicado: (2018)

Perineural spread of recurrent cutaneous melanoma along cervical nerves into the spinal cord
por: Law, W. Phillip, et al.
Publicado: (2017)

Melanoma Biomolecules: Independently Identified but Functionally Intertwined
por: Dye, Danielle E., et al.
Publicado: (2013)

SIRT1 activation mediates heat-induced survival of UVB damaged Keratinocytes
por: Calapre, Leslie, et al.
Publicado: (2017)

Acral Amelanotic Melanoma Mimicking a Non-Healing Arterial Ulcer
por: Cantwell, Phillip, et al.
Publicado: (2019)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

PD‐L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study
por: Khattak, Muhammad A., et al.
Publicado: (2019)

Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
por: Aya-Bonilla, Carlos Alberto, et al.
Publicado: (2020)

Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma
por: Klinac, Dragana, et al.
Publicado: (2014)

Heat-mediated reduction of apoptosis in UVB-damaged keratinocytes in vitro and in human skin ex vivo
por: Calapre, Leslie, et al.
Publicado: (2016)

Mechanisms Contributing to Differential Regulation of PAX3 Downstream Target Genes in Normal Human Epidermal Melanocytes versus Melanoma Cells
por: Bartlett, Danielle, et al.
Publicado: (2015)

Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device
por: Aya-Bonilla, Carlos A., et al.
Publicado: (2017)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
por: Hu, Baohui, et al.
Publicado: (2020)

The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma
por: Song, Le-Bin, et al.
Publicado: (2021)

Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma
por: Xie, Ran, et al.
Publicado: (2020)

Two subtypes of cutaneous melanoma with distinct mutational signatures and clinico-genomic characteristics
por: Kim, Yoon-Seob, et al.
Publicado: (2022)

A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma
por: Xie, Yihui, et al.
Publicado: (2022)

Chromosome instability‐associated prognostic signature and cluster investigation for cutaneous melanoma cases
por: Liu, Ning, et al.
Publicado: (2023)

A Predictive Autoantibody Signature in Multiple Sclerosis
por: Zamecnik, Colin R., et al.
Publicado: (2023)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

The relationship between lifestyle and serum neurofilament light protein in Huntington’s disease
por: Cruickshank, Travis, et al.
Publicado: (2020)

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
por: Johannet, Paul, et al.
Publicado: (2022)

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies
por: Okiyama, Naoko, et al.
Publicado: (2019)

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
por: Fröhlich, Fabienne, et al.
Publicado: (2023)

Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease
por: Bartlett, Danielle M., et al.
Publicado: (2018)

A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging
por: Brunner, Georg, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s92gln0e01u1utcq0ceuv0tfq5